This review paper highlights preclinical and clinical studies indicating that GLP-1 drugs, including low dose formulations such as exenatide, may offer neuroprotective benefits by targeting hallmarks of brain aging through enhancing DNA repair, boosting antioxidant responses, reducing inflammation and improving mitochondrial function
NZ Drug Foundation drug checking machines can test for over 30,000 different substances, but peptides have been hard to detect because of their molecule make up, Hughes says
And, the issue here is that once you reach a target body weight, the indication for the medication should, in theory, not be present anymore
When you escalate from 0.5 mg to 1.0 mg of semaglutide, for example, the nausea pattern may reset
I wish some of the others were a bit less but happy